MEDI-5884 is a humanized IgG4Pkappa neutralizing monoclonal antibody that targets endothelial lipase (EL). By inhibiting EL, MEDI-5884 leads to an increase in high-density lipoprotein (HDL) levels, particularly phosphatidylinositol and cholesterol ester, thereby enhancing its functionality. This compound is applicable in research related to cardiovascular diseases, such as coronary artery disease (CAD).
CAS Number:
[2643310-75-0]
Target:
Lipase
* VAT and and shipping costs not included. Errors and price changes excepted
